This week, on behalf of its members, BIOQuébec signed a letter adressing the Patented Medicines Price Reform with some of our industry's biggest stakeholders.
Read More
Behavioural economics will become essential to the future success of life sciences companies
Read More
Data monetization, direct-to-consumer and eCommerce business models will create growth opportunities, finds Frost & Sullivan
An initiative to grow Western Australia’s life sciences and innovation sector and boost local research capability was announced today as part of a collaboration between the State Government, The University of Western Australia and MTPConnect.
BIOQuébec and Triumvirate Environmental are pleased to announce they have finalized a collaboration agreement aiming to promote access for BIOQuébec members to products and services that will allow them to implement and maintain safe and sustainable laboratory practices.
Read More
BIOQUÉBEC ATTENDED BIO 2018, A PRESTIGIOUS CONFERENCE HELD IN BOSTON FROM JUNE 4TH TO JUNE 7TH, WITH A QUEBEC DELEGATION CONSISTING OF MORE THAN 50 LIFE SCIENCES COMPANIES UNDER THE MESI'S LEADERSHIP.
Read More
GSK and NEOMED are calling on Quebec-based researchers to submit their innovative projects in early drug discovery for potential funding under the GSK and NEOMED $2 million Discovery Fund.
Read More
To repair a defect in the genome of an organism, one would have to remove, alter, or insert a genetic code at atomically precise locations in the DNA sequence. This vision is now a reality with CRISPR-Cas9, a nanotool that opens a door towards curing hereditary diseases and boosting agriculture.
Read More
"Our investment in this program, and partnership with BC Tech, is pivotal in advancing entrepreneurship, and simultaneously supporting growth for BC-based companies," says Dr. Tony Brooks, Chief Financial Officer and Vice President, Entrepreneurship and Commercialization.
Read More
The bill (H 4501) provides about $463 million in new capital authorizations for the state Life Sciences Capital Fund
Read More
Acquisition Expands Lilly Oncology Pipeline with Early-Phase Asset Being Studied in Multiple Tumor Types
Read More
According to Hays in Singapore, the unexpected GDP growth in 2017 plus the strong and stable growth predicted for this year, means there is rise in demand for candidates in the commercial sectors and manufacturing parts of the life sciences industry. The growth is also being fuelled by the industry’s attention to the arrival of digital health and AI.
Read More
Living standards in the United States increasingly depend on the competitiveness of industries that compete internationally, particularly those that succeed by producing new innovations. The life-science sector, which includes pharmaceuticals, biotechnology, and medical devices, is one of those industries.
Read More
By the 30th of March 2019, the UK will officially exit the EU, in a move that is popularly known as Brexit. With this date fast approaching, companies, organizations and individuals all over the world have speculated about how Brexit might impact them.
Read More
Big Data Plus Machine Learning Equals Scientific Advancement
Read More
MassBio’s 2018 Annual Meeting - Building tomorrow's life sciences industry together.
Read More
“Mapping the potential – Profiles of Canada’s biotech frontiers,” is BioTalent Canada’s first labour market information report that includes both national and provincial bio-economy snapshots. The report displays the diverse initiatives and growth of companies across Canada; the potential talent to help grow the industry and the positive impact of BioTalent Canada’s many wage subsidy programs on the industry.
Read More
BIOQuébec welcomes the Québec government’s 2018-2019 budget, which is both balanced and focused on investments designed to improve the quality of life of the province’s population, a factor to which the biotechnology and life sciences industry contributes.
Read More